SafeShot Technologies Names Michael J. Madden as New Board Member

Share Article

Company Continues to Attract Healthcare Experts Advocating Against the Global Spread of HIV and Hepatitis from Contaminated Needles

News Image
said SafeShot Technologies Co-Founder Dan Thayer.

SafeShot Technologies, LLC, a leader in safety syringe innovation, today announced a new Board Member – Michael J. Madden, formerly Vice President of Advocacy and Development, for Providence Health & Services, a 26-hospital, $6 billion nonprofit health system serving five states. Mr. Madden currently serves as a board member to Providence High School Board of Regents and the American Hospital Association. He brings a wealth of knowledge in Hospital administration and is an advocate for ending the global needlestick safety issue.

According to the World Health Organization, someone dies every 24 seconds from an unsafe injection; that’s 1.3 million preventable deaths each year,” said SafeShot Technologies Co-Founder Dan Thayer. “22 million more are infected with HIV, Hepatitis and more. Nearly 1 million people in the US alone are victims of needlestick injuries, which cost the healthcare system $1.2 billion.”

The 2008 Study of Nurses Views on Workplace Safety and Needlestick Injuries by the American Nurses Association reveals Needlestick Injuries (NSIs) and blood-borne infections remain a major concern in the U.S., with two-thirds of all nurses having been accidentally stuck by a needle while working. Despite the Needlestick Safety and Prevention Act of 2000, many healthcare professionals ten years later are still not being equipped with safety solutions to eliminate exposure to blood borne pathogens and sharps injuries.

“I’ve been in the hospital business for a long time, and needlestick injuries have always been an issue for me and for the institutions that I’ve managed,” said Mr. Madden. “Getting involved with a company that could reduce the threat of needles to healthcare and housekeeping staff who are picking up the trash and getting stuck with needles, seemed like a great opportunity. I’ve seen first-hand in Africa and other developing countries how needed this technology is to underdeveloped countries where needle reuse is an enormous issue.”

SafeShot Technologies’ affordable Epiphany Safety Syringe – a one-handed, single use, auto-retractable, auto-disabled safety syringe that upon use, retracts and securely holds the contaminated needle portion in the barrel cylinder for disposal eliminating any risk of getting pricked or exposed to blood borne viruses such as Hepatitis or HIV. After a single injection, the needle is permanently disabled.

“Shots clearly aren’t as safe as they could be,” said Mr. Madden. “Having a safe delivery system is imperative for the future safety of anyone in contact with a needle. One of the things that hospitals and other institutions have not had is a product that would both simplify and make automatic the safety challenge of needles. SafeShot’s technology takes the quality of hospital needle safety to a whole new level and should be looked upon as a very favorable improvement to the steps that nurses and others go through when using needles.”

The U.S. General Accounting Office estimated that the annual out-of-pocket costs of treating U.S. hospital needlestick injuries were between $37 million and $173 million. And EcoMed, Inc. reports, globally, 60%-80% needlestick injuries go unreported.

“The high cost and complexity of spring-loaded, retractable syringes have limited the adoption of safety syringes in hospitals and places where shots are administered,” said SafeShot Technologies Co-Founder Dan Thayer. “We are very excited to have Michael Madden evangelize the healthcare industry on a revolutionary technology that will break down cost barriers and ultimately save lives.”

Mr. Madden previously served as Vice President/Chief Executive for Providence Health & Services –California Region. In 1993, the Providence Saint Joseph Medical Center operation was a 600-bed hospital with annual revenues in 1992 of $168 million and an operations loss of $11.7 million. Under Mr. Madden’s leadership, the Southern Californian presence grew to more than 1,000 acute beds and 7,600 employees. In 2006, total revenues for the Region were $940 million with income from operations of $36.6 million. From 2006 to 2009, Mr. Madden served as Vice President of Advocacy and Development, for Providence Health & Services, a 26-hospital, $6 billion nonprofit health system serving five states. Mr. Madden received a Bachelor of Science degree from University of Wisconsin, Master of Health Administration from University of Minnesota, and an Advanced Management Program degree from Harvard.

About SafeShot Technologies
SafeShot Technologies, headquartered in Mission Viejo, California, is a new generation safety syringe development company with the mission to solve the needlestick issue with innovative technology. The Epiphany Safety Syringe is the first patented vacuum-triggered, one-handed, single-use, auto-retractable, auto-disabled safety syringe designed to provide superior value. There are an estimated 1 million needlestick injuries among 8.8 million workers in the U.S. SafeShot has more than a dozen U.S. patent applications and foreign counterparts in other major jurisdictions to address this growing problem. For more information on SafeShot Technologies and the Epiphany Safety Syringe, please visit

John Sperrazzo
Eye-To-Eye Communications, Inc.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Sperrazzo
Visit website